Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 7;22(45):9966-9973.
doi: 10.3748/wjg.v22.i45.9966.

Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes

Neil Rajoriya  1 , Dhiraj Tripathi  1 , Joanna A Leithead  1 , Bridget K Gunson  1 , Sophie Lord  1 , James W Ferguson  1 , Gideon M Hirschfield  1
Affiliations

Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes

Neil Rajoriya et al. World J Gastroenterol. .

Abstract

Aim: To establish the impact of portal hypertension (PH) on wait-list/post-transplant outcomes in patients with polycystic liver disease (PCLD) listed for liver transplantation.

Methods: A retrospective single-centre case controlled study of consecutive patients listed for liver transplantation over 12 years was performed from our centre. PH in the PCLD cohort was defined by the one or more of following parameters: (1) presence of radiological or endoscopic documented varices from our own centre or the referral centre; (2) splenomegaly (> 11 cm) on radiology in absence of splenic cysts accounting for increased imaging size; (3) thrombocytopenia (platelets < 150 × 109/L); or (4) ascites without radiological evidence of hepatic venous outflow obstruction from a single cyst.

Results: Forty-seven PCLD patients (F: M = 42: 5) were listed for liver transplantation (LT) (single organ, n = 35; combined liver-kidney transplantation, n = 12) with 19 patients (40.4%) having PH. When comparing the PH group with non-PH group, the mean listing age (PH group, 50.6 (6.4); non-PH group, 47.1 (7.4) years; P = 0.101), median listing MELD (PH group, 12; non-PH group, 11; P = 0.422) median listing UKELD score (PH group, 48; non-PH group, 46; P = 0.344) and need for renal replacement therapy (P = 0.317) were similar. In the patients who underwent LT alone, there was no difference in the duration of ICU stay (PH, 3 d; non-PH, 2 d; P = 0.188), hospital stay length (PH, 9 d; non-PH, 10 d; P = 0.973), or frequency of renal replacement therapy (PH, 2/8; non-PH, 1/14; P = 0.121) in the immediate post-transplantation period.

Conclusion: Clinically apparent portal hypertension in patients with PCLD listed for liver transplantation does not appear to have a major impact on wait-list or peri-transplant morbidity.

Keywords: Liver transplantation; Polycystic liver disease; Portal hypertension.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors state no conflict on interest.

Similar articles

See all similar articles

Cited by

References

    1. Berrebi G, Erickson RP, Marks BW. Autosomal dominant polycystic liver disease: a second family. Clin Genet. 1982;21:342–347. - PubMed
    1. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet. 1963;117:659–676. - PMC - PubMed
    1. Qian Q. Isolated polycystic liver disease. Adv Chronic Kidney Dis. 2010;17:181–189. - PMC - PubMed
    1. Tahvanainen P, Tahvanainen E, Reijonen H, Halme L, Kääriäinen H, Höckerstedt K. Polycystic liver disease is genetically heterogeneous: clinical and linkage studies in eight Finnish families. J Hepatol. 2003;38:39–43. - PubMed
    1. Onori P, Franchitto A, Mancinelli R, Carpino G, Alvaro D, Francis H, Alpini G, Gaudio E. Polycystic liver diseases. Dig Liver Dis. 2010;42:261–271. - PMC - PubMed

MeSH terms

Supplementary concepts